β¨ Medicines Act Notices
710 NEW ZEALAND GAZETTE No. 27
Health
Medicines Act 1981
Corrigendum
Consent to the Distribution of a New Related Product
In the notice published in the New Zealand Gazette, 4 February 1999, No. 16, page 365, notice number 758, amend the first entry to show the Proprietary Name as Colgate Sensation Whitening Fluoride Toothpaste plus Tartar Control.
Dated this 28th day of February 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go1722
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin | Cement, bone | DePuy CMW, Blackpool, United Kingdom | CMW 1 Gentamicin Bone Cement |
| Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin | Cement, bone | DePuy CMW, Blackpool, United Kingdom | CMW 3 Gentamicin Bone Cement |
| Raloxifene hydrochloride 60 mg equivalent to 56 mg raloxifene | Tablet, film coated | Eli Lilly & Company Limited, Basingstoke, Hampshire, England; and Lilly del Caribe Inc., Carolina, Puerto Rico | Evista |
| Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin | Cement, bone | DePuy CMW, Blackpool, United Kingdom | Vacu-Mix Plus (with CMW 1 Gentamicin Bone Cement) |
| Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin | Cement, bone | DePuy CMW, Blackpool, United Kingdom | Vacu-Mix Plus (with CMW 3 Gentamicin Bone Cement) |
Dated this 23rd day of February 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go1560
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Somatropin 4IU: and benzyl alcohol 0.9% as diluent | Injection, powder, with diluent | Novo Nordisk A/S., Gentoft, Denmark | Norditropin 4IU |
| Somatropin 12IU: and benzyl alcohol 0.9% as diluent | Injection, powder, with diluent | Novo Nordisk A/S., Gentoft, Denmark | Norditropin 12IU |
| Somatropin 12IU: and benzyl alcohol 0.9% as diluent | Injection, powder, with diluent | Novo Nordisk A/S., Gentoft, Denmark | Norditropin PenSet 12 |
| Somatropin 24IU: and benzyl alcohol 0.9% as diluent | Injection, powder, with diluent | Novo Nordisk A/S., Gentoft, Denmark | Norditropin PenSet 24 |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 27
NZLII —
NZ Gazette 1999, No 27
β¨ LLM interpretation of page content
π₯ Corrigendum to Distribution Consent for Colgate Sensation Whitening Fluoride Toothpaste
π₯ Health & Social Welfare28 February 1999
Medicines Act 1981, Corrigendum, Distribution Consent, Toothpaste
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare23 February 1999
Medicines Act 1981, Distribution Consent, New Medicines, Gentamicin, Raloxifene
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act 1981, Distribution Consent, Changed Medicines, Somatropin